Dow Today: United Technologies (UTX) Leads The Day Higher, Johnson & Johnson (JNJ) Lags
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link
.
The
Dow Jones Industrial Average
(
^DJI
) closed up 66 points (+0.4%) at 14,963. During the day, 420.9 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 549.9 million. The NYSE advances/declines ratio closed at 2,572 issues advancing vs. 480 declining with 74 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component that led the way higher today was
(NYSE:
), which sported a $1.26 gain (+1.2%) bringing the stock to $102.96. This single gain lifted the Dow Jones Industrial Average by 9.54 points or roughly accounting for 14.5% of the Dow's overall gain. Volume for United Technologies ended the day at 2.7 million shares traded vs. an average daily trading volume of 3.3 million shares.
United Technologies has a market cap of $93.95 billion and is part of the industrial goods sector and industrial industry. Shares are up 24% year to date as of Wednesday's close. The stock's dividend yield sits at 2.1%.
United Technologies Corporation provides technology products and services to the building systems and aerospace industries worldwide.
TheStreet Ratings rates United Technologies as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.
- You can view the full United Ratings Report.
Holding the Dow back today was
(NYSE:
), which lagged the broader Dow index with a 54-cent decline (-0.6%) bringing the stock to $88.26. Volume for Johnson & Johnson ended the day at 7.1 million shares traded vs. an average daily trading volume of 9.9 million shares.
- See our dividend calendar or top-yielding stocks list.
Johnson & Johnson has a market cap of $252.87 billion and is part of the health care sector and drugs industry. Shares are up 26.7% year to date as of Wednesday's close. The stock's dividend yield sits at 2.9%.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.
TheStreet Ratings rates Johnson & Johnson as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
- You can view the full Johnson & Johnson Ratings Report.
.
null
